Progenics Pharmaceuticals, Inc.
Overview
Progenics Pharmaceuticals, Inc. is an oncology company focused on the development of innovative medicines and artificial intelligence to find, fight and follow cancer. It is a subsidiary of Lantheus Holdings, Inc.
Therapeutic areas
FDA compliance signals
8 FDA enforcement records linked to this company.
- 4832020-03-20
Aseptic Processing Area
- 4832020-03-20
Adequate space lacking to prevent mix-ups and contamination
- 4832020-03-20
Procedures for sterile drug products
- 4832020-03-20
Procedures not in writing, fully followed
- 4832020-03-20
Computer control of master formula records
- 4832020-03-20
Review of representative number of batches
- 4832020-03-20
Incoming material area
- 4832020-03-20
Investigations of discrepancies, failures
Is this Progenics Pharmaceuticals, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.